Greystone Associates
The Power of Insight
Drugs based on immune factors - a class
that includes cytokines, lymphocyte receptors,
signaling enzymes, antibodies and transcription
factors - have demonstrated the capability to
effectively treat a host of diseases that had
previously been considered to be
intractable.........more
While the ability of
recombinant protein drugs to treat previously
refractory conditions continues to generate
excitement and investment, the complex structure of
these therapeutic substances require special
formulation and delivery strategies, creating
special challenges for drug developers and their
formulation technology
........more
Within the
injectable segment, the sands are shifting as
several factors converge to drive demand for
delivery methods that increase safety,
compliance and ease-of-use. While the economics
of traditional disposable syringe devices remain
compelling, a number of companies are combining
synthetic materials .....more